Santersus AG is proud to announce the successful publication of its latest research, “Restoring discarded porcine lungs by ex vivo removal of neutrophil extracellular traps”, in the prestigious Journal of Heart and Lung Transplantation. This innovative work offers a transformative solution to address the global shortage of viable lungs for transplantation, utilizing advanced ex vivo lung perfusion (EVLP) techniques to repair lungs previously deemed unusable.
The study, led by Santersus AG’s team of researchers, focuses on the role of neutrophil extracellular traps (NETs) in causing inflammation and damage to lungs, contributing to the high rejection rate of organs. By employing cutting-edge therapeutic strategies to remove NETs ex vivo, using Santersus’ patented NucleoCapture technology, the research demonstrates significant improvements in lung function, offering new hope for increasing the pool of transplantable lungs.
Accompanying our publication is an editorial titled “Commentary on: Restoring discarded porcine lungs by ex vivo removal of neutrophil extracellular traps,” which highlights the profound potential of this approach in the future of organ transplantation and supports the validity and importance of our findings.
Access the full publication and accompanying commentary below